SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of INC Research Holdings, Inc. - INCR

NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether INC Research and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here to join a class action]

On August 1, 2017, INC Research and inVentiv Health, Inc. ("inVentiv Health") announced the completion of a merger between the two companies.  On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health.  The Company's combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses.  

On this news, INC Research's share price fell $16.35, or 28.43%, to close at $41.15 on November 9, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-inc-research-holdings-inc--incr-300553910.html

SOURCE Pomerantz LLP